Common Contracts
2 similar Consulting Agreement contracts by Gemphire Therapeutics Inc.
Consulting AgreementConsulting Agreement • December 31st, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (“Agreement”) is effective as of May 1, 2018 by and between NeuroBo Pharmaceuticals, Inc. (“NeuroBo”), a Massachusetts corporation with its principal place of business at 177 Huntington Avenue, Suite 1732, Boston, MA 02115 (email — jkang@jkbiopharma.com) and vZenium LLC (“Consultant”), a Massachusetts limited liability company, owned and managed entirely by Mark Versavel, MD, PhD, MBA with a principal place of business at 47 Marathon Street, Arlington, MA 02474 (email - mark.versavel@vzenium.com).
Consulting AgreementConsulting Agreement • September 3rd, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (“Agreement”) is effective as of February 1, 2018 by and between NeuroBo Pharmaceuticals, Inc. (“NeuroBo”), a Massachusetts corporation with its principal place of business at 177 Huntington Avenue, Suite 1732, Boston, MA 02115 (email — jkang@jkbiopharma.com) and vZenium LLC (“Consultant”), a Massachusetts limited liability company, owned and managed entirely by Mark Versavel, MD, PhD, MBA with a principal place of business at 47 Marathon Street, Arlington, MA 02474 (email - mark.versavel@vzenium.com).
